**Bevel Secures $10M Series A Led by General Catalyst to Advance AI Health Companion**
Bevel, an innovator in the digital health space, has announced the successful closure of a $10 million Series A funding round. The investment was led by prominent venture capital firm General Catalyst, signaling strong confidence in Bevel’s vision for the future of personalized health.
The capital will primarily fuel the expansion and further development of Bevel’s flagship AI health companion. This intelligent platform aims to empower individuals with proactive, data-driven insights and support for managing their well-being, leveraging artificial intelligence to create more personalized and accessible healthcare experiences.
With this significant backing, Bevel plans to accelerate product innovation, scale its operations, and grow its team of experts in AI, healthcare, and engineering. The investment underscores the growing interest in AI’s transformative potential within the health sector, positioning Bevel to make a substantial impact on how people interact with and manage their health.